Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1996 Apr;178(8):2455–2458. doi: 10.1128/jb.178.8.2455-2458.1996

Quinine specifically inhibits the proteolipid subunit of the F0F1 H+ -ATPase of Streptococcus pneumoniae.

R Muñoz 1, E García 1, A G De la Campa 1
PMCID: PMC177963  PMID: 8636056

Abstract

Streptococcus pneumoniae is uniquely sensitive to quinine and its derivatives, but only those alkaloids having antimalarial properties, i.e., those in the erythro configuration, also possess antipneumococcal activity. Quinine and related compounds inhibit the pneumococcal H+ -ATPase. Quinine- and optochin-resistant pneumococci showed mutations that change amino acid residues located in one of the two transmembrane alpha-helices of the c subunit of the F0F1, H+ -ATPase.

Full Text

The Full Text of this article is available as a PDF (215.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blum J. J., Yayon A., Friedman S., Ginsburg H. Effects of mitochondrial protein synthesis inhibitors on the incorporation of isoleucine into Plasmodium falciparum in vitro. J Protozool. 1984 Aug;31(3):475–479. doi: 10.1111/j.1550-7408.1984.tb02997.x. [DOI] [PubMed] [Google Scholar]
  2. Choi I., Mego J. L. Purification of Plasmodium falciparum digestive vacuoles and partial characterization of the vacuolar membrane ATPase. Mol Biochem Parasitol. 1988 Oct;31(1):71–78. doi: 10.1016/0166-6851(88)90146-6. [DOI] [PubMed] [Google Scholar]
  3. Fenoll A., Muñoz R., García E., de la Campa A. G. Molecular basis of the optochin-sensitive phenotype of pneumococcus: characterization of the genes encoding the F0 complex of the Streptococcus pneumoniae and Streptococcus oralis H(+)-ATPases. Mol Microbiol. 1994 May;12(4):587–598. doi: 10.1111/j.1365-2958.1994.tb01045.x. [DOI] [PubMed] [Google Scholar]
  4. Futai M., Noumi T., Maeda M. ATP synthase (H+-ATPase): results by combined biochemical and molecular biological approaches. Annu Rev Biochem. 1989;58:111–136. doi: 10.1146/annurev.bi.58.070189.000551. [DOI] [PubMed] [Google Scholar]
  5. Ginsburg H., Divo A. A., Geary T. G., Boland M. T., Jensen J. B. Effects of mitochondrial inhibitors on intraerythrocytic Plasmodium falciparum in in vitro cultures. J Protozool. 1986 Feb;33(1):121–125. doi: 10.1111/j.1550-7408.1986.tb05570.x. [DOI] [PubMed] [Google Scholar]
  6. Gray M. W. The evolutionary origins of organelles. Trends Genet. 1989 Sep;5(9):294–299. doi: 10.1016/0168-9525(89)90111-x. [DOI] [PubMed] [Google Scholar]
  7. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983 Jun 5;166(4):557–580. doi: 10.1016/s0022-2836(83)80284-8. [DOI] [PubMed] [Google Scholar]
  8. Homewood C. A., Warhurst D. C., Peters W., Baggaley V. C. Lysosomes, pH and the anti-malarial action of chloroquine. Nature. 1972 Jan 7;235(5332):50–52. doi: 10.1038/235050a0. [DOI] [PubMed] [Google Scholar]
  9. Mandel M., Moriyama Y., Hulmes J. D., Pan Y. C., Nelson H., Nelson N. cDNA sequence encoding the 16-kDa proteolipid of chromaffin granules implies gene duplication in the evolution of H+-ATPases. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5521–5524. doi: 10.1073/pnas.85.15.5521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Miller M. J., Oldenburg M., Fillingame R. H. The essential carboxyl group in subunit c of the F1F0 ATP synthase can be moved and H(+)-translocating function retained. Proc Natl Acad Sci U S A. 1990 Jul;87(13):4900–4904. doi: 10.1073/pnas.87.13.4900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Most H. Treatment of parasitic infections of travelers and immigrants. N Engl J Med. 1984 Feb 2;310(5):298–304. doi: 10.1056/NEJM198402023100507. [DOI] [PubMed] [Google Scholar]
  12. Nelson H., Nelson N. The progenitor of ATP synthases was closely related to the current vacuolar H+-ATPase. FEBS Lett. 1989 Apr 10;247(1):147–153. doi: 10.1016/0014-5793(89)81259-1. [DOI] [PubMed] [Google Scholar]
  13. Phillips R. E., Warrell D. A., White N. J., Looareesuwan S., Karbwang J. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med. 1985 May 16;312(20):1273–1278. doi: 10.1056/NEJM198505163122001. [DOI] [PubMed] [Google Scholar]
  14. Senior A. E. The proton-translocating ATPase of Escherichia coli. Annu Rev Biophys Biophys Chem. 1990;19:7–41. doi: 10.1146/annurev.bb.19.060190.000255. [DOI] [PubMed] [Google Scholar]
  15. Tomasz A. Cellular metabolism in genetic transformation of pneumococci: requirement for protein synthesis during induction of competence. J Bacteriol. 1970 Mar;101(3):860–871. doi: 10.1128/jb.101.3.860-871.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. White N. J., Looareesuwan S., Warrell D. A., Chongsuphajaisiddhi T., Bunnag D., Harinasuta T. Quinidine in falciparum malaria. Lancet. 1981 Nov 14;2(8255):1069–1071. doi: 10.1016/s0140-6736(81)91275-7. [DOI] [PubMed] [Google Scholar]
  17. Wyler D. J. Malaria--resurgence, resistance, and research (second of two parts). N Engl J Med. 1983 Apr 21;308(16):934–940. doi: 10.1056/NEJM198304213081605. [DOI] [PubMed] [Google Scholar]
  18. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 1985;33(1):103–119. doi: 10.1016/0378-1119(85)90120-9. [DOI] [PubMed] [Google Scholar]
  19. van Es H. H., Skamene E., Schurr E. Chemotherapy of malaria: a battle against all odds? Clin Invest Med. 1993 Aug;16(4):285–293. [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES